Your browser doesn't support javascript.
loading
Off-Label High-Dose Secukinumab for the Treatment of Moderate-to-Severe Psoriasis.
Phung, Michelle; Ighani, Arvin; Georgakopoulos, Jorge R; Vender, Ron; Giroux, Lyne; Lansang, Perla; Yeung, Jensen.
Afiliação
  • Phung M; 1 Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, ON, Canada.
  • Ighani A; 2 Faculty of Medicine, University of Toronto, ON, Canada.
  • Georgakopoulos JR; 3 Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
  • Vender R; 4 Dermatrials Research Inc, Hamilton, ON, Canada.
  • Giroux L; 5 Venderm Innovations in Psoriasis, Hamilton, ON, Canada.
  • Lansang P; 6 Department of Dermatology, The Northern Ontario School of Medicine, Sudbury, Canada.
  • Yeung J; 7 Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
J Cutan Med Surg ; 23(4): 391-393, 2019.
Article em En | MEDLINE | ID: mdl-30991818
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Fármacos Dermatológicos / Anticorpos Monoclonais Humanizados Tipo de estudo: Observational_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article